[Accepted, unedited version] The dark side of drug repurposing, from clinical trial challenges to antimicrobial resistance: analysis based on three major fields
Drug repurposing is a strategic endeavor that entails the identification of novel therapeutic applications for pharmaceuticals that are already available in the market. Despite the advantageous nature of implement- ing this particular strategy owing to its cost-effectiveness and efficiency in reduci...
Saved in:
Main Authors: | Iyad Y. Natsheh (Author), Majd M. Alsaleh (Author), Ahmad K. Alkhawaldeh (Author), Duaa K. Albadawi (Author), Maisa' M. Darwish (Author), Mohammed Jamal A. Shammout (Author) |
---|---|
Format: | Book |
Published: |
AboutScience Srl,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
[Accepted version, unedited] Unmet needs for management of drug resistant infections
by: Monica Sharma, et al.
Published: (2022) -
[Final accepted version, unedited] Antimicrobial resistance surveillance system mapping in different countries
by: Ramendra Pati Pandey, et al.
Published: (2022) -
[Final accepted version, unedited] Understanding the Environmental Drivers of Clinical Azole Resistance in Aspergillus Spp.
by: Pooja Sen, et al.
Published: (2022) -
[Accepted version, unedited] Current molecular approach for diagnosis of MRSA: A meta-narrative review.
by: Yi Xing Sim, et al.
Published: (2022) -
The dark side of paclitaxel
by: Alekha K. Dash
Published: (2011)